Company intelligence / Profile preview

Clover Pharmaceuticals

Sichuan, China

Ownership: Private
Development stage: Other

Overview

Clover Pharmaceuticals is a clinical- to commercial-stage vaccine and biologics company using its Trimer-Tag technology to develop recombinant protein vaccines and biologics for infectious and immune-related diseases. It has advanced a COVID-19 vaccine and multiple respiratory virus vaccine candidates into clinical trials, including Phase 1 combination RSV-hMPV-PIV3 programs and revaccination studies in older adults, with a broader pipeline in infectious diseases, cancer, and autoimmune disorders.[1][3][4][2]

Therapeutic areas: OncologyRheumatologyInfectious Diseases
Modalities: VaccineBiologicRecombinant protein
Industry: Biotech

Partnerships

Global health organizations (unspecified)Other international vaccine and biotechnology partners (unspecified)

Beyond the preview

Go deeper on Clover Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clover Pharmaceuticals.

Explore the full profile